Knowledge Center

Brochures & Service Guides

Pharmaceutical

Independent Expertise for Stability Studies

Stability studies are essential in ensuring drug products remain safe, effective, and high-quality throughout their shelf life. While bundled services often include stability testing, hidden costs and limitations can create challenges. 

Click to download

Pharmaceutical Nicotine Cannabinoids

Broughton - Your Innovation Partner

Broughton is a leading global contract research organisation specialising in tobacco harm reduction, medicinal cannabis, cannabinoids, and pharmaceuticals, we can help bring category innovators life-enhancing products to market.

Click to download

Pharmaceutical Nicotine Cannabinoids

ICH Product Stability Storage and Analysis Brochure

With over 60,000 liters of in-house ICH stability storage capacity, supported by a team of highly qualified scientists and GMP-accredited laboratory testing facilities, we have approximately 250 live studies in progress and offer a full range of stability services to help bring your product to market or ensure its ongoing compliance requirements.

 

Click to download

Pharmaceutical

Guide: Conquering stability hurdles in pharmaceutical inhalation

For category innovators thorough stability studies are vital for successful drug development and regulatory approval.

Click to download

Pharmaceutical

A Guide To Pharmaceutical Marketing Authorisation in the UK

The MHRA is now a stand-alone body issuing national authorisations only. This infographic outlines the routes to a Pharmaceutical Marketing Authorisation in the UK.

Click to download

Pharmaceutical Nicotine Cannabinoids

Pharmaceutical Services - Extractables and Leachables

The evaluation of extractables and leachables (E&L) is an essential component of the pharmaceutical development process.

Click to download

Pharmaceutical Nicotine Cannabinoids

Toxicology Advice and Consultancy Services

Our team of in-house toxicologists reviews and evaluates toxicological data on a wide range of chemicals to produce independent expert opinions on risk assessment. We then advise on the strategies to mitigate or reduce those risks to protect corporate reputation and public health.

Click to download

Pharmaceutical

Pharma Inhalation Services

Developing and commercializing new inhaled drug products, requires huge energy and deep scientific understanding. This level of resource and subject matter expertise can be difficult to maintain inside your business, and that is where we can help.

Click to download

Pharmaceutical Nicotine Cannabinoids

Technical Due Diligence: Product Realization Services

Our product development and regulatory experts can help you meet expectations at key milestones in your product development project to better inform decision making and investment choices.

Click to download

Pharmaceutical Nicotine Cannabinoids

Quality Policy

We believe that the sectors we work within expect a continually improving service where we constantly strive to improve processes and Quality.

Click to download

Whitepapers & Posters

Pharmaceutical Nicotine Cannabinoids

Introducing ToxHQ

ToxHQ by Broughton offers automated, data-driven risk assessments and delivers fast, high-quality toxicological evaluations, so you can launch safer products with confidence.

Click to download

Pharmaceutical Nicotine Cannabinoids

Whitepaper: Designing a Bespoke Stability Study

In this whitepaper, we discuss the stability studies that may be performed during pharmaceutical development and in support of a regulatory dossier to support the licensing of a medicinal drug product.

Click to download

Pharmaceutical

Whitepaper: What are Stability Studies - An Introductory Guide

In this whitepaper, we discuss the stability studies that may be performed during pharmaceutical development and in support of a regulatory dossier to support the licensing of a medicinal drug product.

Click to download

Pharmaceutical

Whitepaper: The Use of Risk Assessments to Optimize your Extractables and Leachables Strategy

Extractables and leachables (E&L) risk assessments are valuable processes that can identify and highlight the risks of potential leachables from both the container closure system and the manufacturing processes. The risk assessments also include the level of risk that leachables might present to user safety and product quality. Download this Whitepaper to learn more.

Click to download

Pharmaceutical

Whitepaper: Improving the Sustainability of Pressurised Metered Dose Inhalers

Since their introduction in 1956, pressurised metered dose inhalers (pMDIs) have become the dominant treatment choice for patients suffering from common respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). However, unbeknown to most patients and many doctors, pMDIs account for 3.9% of NHS’s annual carbon emissions. 1Here we will discuss how formulation changes might be the answer to the pMDI-related sustainability problem.

Click to download

Pharmaceutical Nicotine

Expert Opinion: A Novel Approach to Inhalation Therapy

The adaptation of e-cigarettes as drug delivery devices holds great potential for inhalation therapy. So, can we apply the advances made in nicotine delivery to other active substances?

Click to download